Other Modified Nucleosides
2'-Deoxy-3-methyl-3,4-dihydrocytidine
Quick view. A 2'-deoxycytidine derivative with N3 methylation and a 3,4-dihydro pyrimidine base. CAS 5040-21-1. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
2'-Deoxy-3-methyl-3,4-dihydrocytidine is classified as other modified nucleosides (Formula C10H17N3O4; molecular weight 243.26 g/mol).
2'-Deoxy-3-methyl-3,4-dihydrocytidine is associated with cytosine-containing building blocks or substrates for C-position incorporation and analytical comparison.
For 2'-Deoxy-3-methyl-3,4-dihydrocytidine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- N3-Me-2'-dC
Useful catalog search terms
- 5040-21-1
Physicochemical data
| Nucleoside scaffold | 2'-Deoxycytidine |
|---|---|
| Modification | N3-methyl and 3,4-dihydro |
| Stereochemical boundary | Deoxyribose stereochemistry defined; base stereocenter unspecified in the registry record |
| PubChem CID | 20847520 |
| InChIKey | LVMJWUXGGRMAIW-QRDCSKFFSA-N |
| InChI | InChI=1S/C10H17N3O4/c1-12-8(11)2-3-13(10(12)16)9-4-6(15)7(5-14)17-9/h2-3,6-9,14-15H,4-5,11H2,1H3/t6-,7+,8?,9+/m0/s1 |
| SMILES | CN1C(=O)N([C@H]2C[C@H](O)[C@@H](CO)O2)C=CC1N |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
3'-O-NH₂-2'-dA
Other Modified Nucleosides · CAS: 132471-87-5
BX-MN-00113'-O-NH₂-2'-dC
Other Modified Nucleosides · CAS: 103251-39-4
BX-MN-00123'-O-NH₂-2'-dG
Other Modified Nucleosides · CAS: 132471-91-1
BX-MN-00133'-O-NH₂-2'-dT
Other Modified Nucleosides · CAS: 103251-38-3
BX-MN-00143'-O-Phthalimido-2'-dA
Other Modified Nucleosides · CAS: 132471-93-3
BX-MN-00153'-O-Phthalimido-2'-dG
Other Modified Nucleosides · CAS: 1263039-35-5
Frequently asked questions
Can the package size for 2'-Deoxy-3-methyl-3,4-dihydrocytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-PN-0089 and CAS 5040-21-1, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Other Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.